neurometrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. the company maintains an active research effort

NeuroMetrix, Inc. Common Stock

Bought 25% more NURO

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Bought 20% more NURO

Bought 100% more NURO

New position in NURO

Sold all NURO

Adam Collins

Tyler Caruso

Bought 33% more NURO

Bought 6% more NURO

Bought 104% more NURO

Bought to close 185% NURO

Sold 217% of NURO

Brian Stainbrook